If you’ve ever seen “Splice” you can probably assume that the incorporation of animal DNA into human bodies is slowly becoming a reality. Zebrafish compounds have been used to manage metabolism. Squalamine in sharks have cured infectious diseases. Now, brain cells from pigs are being implanted into humans in the hopes of treating Parkinson’s Disease.
New Zealand biotech company Living Cell Technologies has developed a treatment for Parkinson’s disease using choroid plexus cells from pigs.
“It’s putting in a little neurochemical factory to promote new nerve cell growth and repair,”
While Living Cell Technologies have yet to see how this new technique stacks up to already existing treatments, they are hopeful for its success.
Assuming this treatment is effective, it may be extended to treat other neurological disorders such as Huntington’s and Alzheimer’s.
Successful treatments for Parkinson’s disease could help millions of people — up to one million in the U.S., and an estimated seven to 10 million around the world. About 60,000 people in the U.S. are diagnosed with Parkinson’s annually.
Parkinson’s Disease sees the gradual loss of dopamine-making brain cells. Many cases of Parkinson’s remain mostly undetected.